ARCHIVES

Includes April issue of Business & Regulatory Report (8 pages).

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Advanced Screening Provides More Accurate Diagnosis

February 23, 2007

Calif., Illinois Enact ACCC Model Law On Reimbursement

October 23, 1992

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

July 17, 1987